Andrew Farland to Humans
This is a "connection" page, showing publications Andrew Farland has written about Humans.
Connection Strength
0.029
-
Liou AA, Skiver BM, Yates E, Persad P, Meyer D, Farland AM, Rocco MV. Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report. Am J Kidney Dis. 2019 05; 73(5):615-619.
Score: 0.009
-
Kuhlman P, Miller P, Farland A, Owen J, Batt K. Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP? J Clin Apher. 2018 Aug; 33(4):541-545.
Score: 0.008
-
Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange. Am J Hematol. 2014 Jul; 89(7):695-7.
Score: 0.006
-
Knovich MA, Farland A, Owen J. Long-term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements. Eur J Haematol. 2012 Jun; 88(6):518-25.
Score: 0.006